Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Oncology·MeSH: Leukemia, Lymphocytic, Chronic, B-Cell

Prevalence

20.0 / 100K

Incidence

4.7 / 100K/yr

8 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Compare drugs

Jaypirca vs BendamustineJaypirca vs BGB-16673Jaypirca vs Idelalisib

Frequently asked questions

How many drugs are in development for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma?

BioSniper tracks 8 drugs in development for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma across 4 companies.

How many clinical trials target Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma?

There are 1 clinical trial targeting Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma tracked by BioSniper.

What is the prevalence of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma?

The estimated prevalence of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma is approximately 20.0 per 100,000 population.

Deep-dive into Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis